These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36282720)

  • 1. Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administration.
    Kenneally AM; Agbana P; Gardner B; Bae Y; Mitchell T; Beckman EJ
    Am J Health Syst Pharm; 2023 Jan; 80(3):164-170. PubMed ID: 36282720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical compatibility of tedizolid phosphate with selected i.v. drugs during simulated Y-site administration.
    Ghazi I; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2016 Nov; 73(21):1769-1776. PubMed ID: 27769972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.
    Foushee JA; Meredith P; Fox LM; Wilder AG
    Am J Health Syst Pharm; 2020 Jul; 77(14):1144-1148. PubMed ID: 32537625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
    Asempa TE; Avery LM; Kidd JM; Kuti JL; Nicolau DP
    Am J Health Syst Pharm; 2018 Jul; 75(14):1048-1056. PubMed ID: 29895521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administration.
    Mann HJ; Demmon SL; Boelk DA; Payne CA; Effron MB; Rajagopalan N; Williams MD; Beck GM; Gopalrathnam G
    Am J Health Syst Pharm; 2004 Dec; 61(24):2664-71. PubMed ID: 15646701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions.
    LaPlante KL; Woodmansee S; Mermel LA
    Am J Health Syst Pharm; 2012 Aug; 69(16):1405-9. PubMed ID: 22855107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration.
    Bergquist PA; Hunke WA; Reed RA; Manas D; Forsyth RJ; Kenney RR; Cook J; Holahan M
    J Clin Pharm Ther; 1999 Apr; 24(2):125-32. PubMed ID: 10380064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administration.
    Thabit AK; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2017 Jan; 74(1):e47-e54. PubMed ID: 28007721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
    Ruiz VH; Shen Y; Abouelhassan Y; Fouad A; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2024 Jan; 81(1):e21-e29. PubMed ID: 37740370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility of Omadacycline With Select Parenteral Products in Simulated Y-site Administration.
    Butler DA; Moolick K; McCray D; Gifford M
    Clin Ther; 2023 Nov; 45(11):1137-1141. PubMed ID: 37777376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical and physical compatibility of an intravenous solution of epinephrine with calcium chloride.
    Weeks PA; Teng Y; Wu L; Sun M; Yang Z; Chow DS
    Int J Pharm Compd; 2014; 18(2):152-8. PubMed ID: 24881119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam.
    Wade J; Cooper M; Ragan R
    Hosp Pharm; 2015 May; 50(5):376-9. PubMed ID: 26405323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
    Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL
    Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Compatibility of Ceftazidime-Avibactam and Aztreonam Using Simulated and Actual Y-site Administration.
    O'Donnell JN; Xu A; Lodise TP
    Clin Ther; 2020 Aug; 42(8):1580-1586.e2. PubMed ID: 32684326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration.
    Kondo M; Yoshida N; Yoshida M; Tanaka C; Tagami T; Horikawa K; Sugaya K; Takase H
    Am J Health Syst Pharm; 2023 Jan; 80(1):e53-e58. PubMed ID: 36094564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site Administration.
    Kidd JM; Avery LM; Asempa TE; Nicolau DP; Kuti JL
    Clin Ther; 2018 Feb; 40(2):261-269. PubMed ID: 29290374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supporting the use of sildenafil infusions in paediatric and neonatal intensive care - A compatibility study.
    AlSalman F; Howlett M; Breatnach C; Kelly H; O'Brien F
    Eur J Pharm Biopharm; 2020 Jun; 151():153-161. PubMed ID: 32289494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.
    Housman ST; Tessier PR; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2011 Dec; 68(23):2265-70. PubMed ID: 22095816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical compatibility of milrinone 1 mg/mL with select cardiovascular medications during simulated Y-site administration.
    Griffith SN; Stapleton E; Padilla S; Mruk A; Thomas CA
    Am J Health Syst Pharm; 2020 Nov; 77(23):1938-1940. PubMed ID: 32991671
    [No Abstract]   [Full Text] [Related]  

  • 20. Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration.
    So W; Kim L; Thabit AK; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2017 Jan; 74(1):e55-e63. PubMed ID: 28007722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.